Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Nov 12, 2020 6:05pm
178 Views
Post# 31888656

RE:Looking at NR from BMO

RE:Looking at NR from BMO What it shows to me is that it is now or never for them.

I say it is now though.

With what they have done if they dont have the revenue or havent progressed Aritstotle at all then the price will continue to go down.  Also no more floating of stock.  Already they have done more than they said they would after the last one.

The going excuse for that is that they didnt get the full amount the first time so they wanted it now.  They never said they were going to do that though and had plans based on how much they got.

So the overnight offering was to get what they didnt get out of the last offering.  Again to hire more people and take over more of the lab.  both good things but why do they need to do that.  No way they are hiring more for covid and taking over the lab for just covid.  Supposedly now there is the cure so it would be a poor judgement to base your company off of covid testing long term.

Frankly i view the overnight offering as more of a "hey big buddies this is your time to get in early one last time" rather than needing the cash but maybe I am wrong.
<< Previous
Bullboard Posts
Next >>